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Eccentric ergometer training (EET) is increasingly being proposed as a therapeutic
strategy to improve skeletal muscle strength in various cardiorespiratory diseases, due
to the principle that lengthening muscle actions lead to high force-generating capacity at
low cardiopulmonary load. One clinical population that may particularly benefit from this
strategy is chronic obstructive pulmonary disease (COPD), as ventilatory constraints and
locomotor muscle dysfunction often limit efficacy of conventional exercise rehabilitation in
patients with severe disease. While the feasibility of EET for COPD has been established,
the nature and extent of adaptation within COPD muscle is unknown. The aim of this
study was therefore to characterize the locomotor muscle adaptations to EET in patients
with severe COPD, and compare them with adaptations gained through conventional
concentric ergometer training (CET). Male patients were randomized to either EET (n= 8)
or CET (n = 7) for 10 weeks and matched for heart rate intensity. EET patients trained
on average at a workload that was three times that of CET, at a lower perception of
leg fatigue and dyspnea. EET led to increases in isometric peak strength and relative
thigh mass (p < 0.01) whereas CET had no such effect. However, EET did not result in
fiber hypertrophy, as morphometric analysis of muscle biopsies showed no increase in
mean fiber cross-sectional area (p = 0.82), with variability in the direction and magnitude
of fiber-type responses (20% increase in Type 1, p = 0.18; 4% decrease in Type 2a,
p= 0.37) compared to CET (26% increase in Type 1, p= 0.04; 15% increase in Type 2a,
p= 0.09). EET had no impact on mitochondrial adaptation, as revealed by lack of change
in markers of mitochondrial biogenesis, content and respiration, which contrasted to
improvements (p < 0.05) within CET muscle. While future study is needed to more
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definitively determine the effects of EET on fiber hypertrophy and associated underlying
molecular signaling pathways in COPD locomotor muscle, our findings promote the
implementation of this strategy to improve muscle strength. Furthermore, contrasting
mitochondrial adaptations suggest evaluation of a sequential paradigm of eccentric
followed by concentric cycling as a means of augmenting the training response and
attenuating skeletal muscle dysfunction in patients with advanced COPD.
Keywords: endurance exercise training, COPD, muscle dysfunction, rehabilitation, hypertrophy, cross sectional
area, mitochondrial biogenesis, respiration
INTRODUCTION
Locomotor muscle dysfunction is a highly prevalent and
disabling condition associated with chronic obstructive
pulmonary disease (COPD), and is characterized by significant
weakness and increased fatigability. The structural and metabolic
alterations that underlie these symptoms in patients with COPD
include muscle atrophy and erosion of oxidative capacity, which
is reflected by low mitochondrial content and a fiber-type shift
toward a glycolytic phenotype (Gosker et al., 2007b; Picard et al.,
2008). Of important note, patients who develop these muscle
alterations have a further exacerbation of exercise intolerance, a
reduced health-related quality of life and pre-mature mortality
compared to patients with the same pulmonary disease severity
but normal muscle function (Marquis et al., 2002; Maltais et al.,
2014). Therefore, strategies that target skeletal muscle in COPD
will have a clinically meaningful impact on mobility and health
status.
One increasingly proposed therapeutic strategy targeting
skeletal muscle weakness in cardiorespiratory disease involves
eccentric ergometer training (EET). Eccentric exercise takes
advantage of unique properties of lengthening muscle actions
that lead to a higher force-generating capacity compared to
concentric, shortening actions (Enoka, 1996; Hortobagyi et al.,
1996; LaStayo et al., 2003). Moreover, an additional advantage of
eccentric muscle actions is that they require a lower metabolic
cost and cardiopulmonary load for a given level of force
production. As such, it has been shown that at the same
metabolic demand, eccentric exercise allows for a four- to five-
fold higher muscle mechanical load than conventional concentric
exercise (Lindstedt et al., 2001; Meyer et al., 2003; Isner-
Horobeti et al., 2013). Because the intensity of muscle contraction
is a principal determinant of muscle growth and strength
development, moderate load eccentric-based cycling protocols
are being applied at relatively low cardiovascular demands in
both healthy aging and cardiac disease populations, and shown
to yield significant improvements in skeletal muscle strength
(Meyer et al., 2003; Steiner et al., 2004; Zoll et al., 2006; Gremeaux
et al., 2010).
In the COPD population, both ventilatory constraints and
locomotor muscle weakness limit patients with severe disease
from exercising at intensities high enough to impact muscle
strength and performance. As such, EET is an appealing modality
because it offers the possibility of overloading the muscle to levels
necessary to induce adaptation without also overloading the
respiratory system (Rooyackers et al., 1997; Rocha Vieira et al.,
2011). Indeed, we have previously shown that the ventilatory
requirements to eccentric cycling in patients with severe COPD
were similar to conventional CET despite the former exercise
being performed at an average 5-times higher mechanical
power (Rocha Vieira et al., 2011). Although the feasibility of
this modality for severe COPD patients has been established
(Rooyackers et al., 2003; Rocha Vieira et al., 2011), the impact
of EET on muscle strength and cellular adaptation has not been
investigated. Furthermore, whereas previous reports in healthy
elderly subjects and patients with coronary artery disease suggest
that EET induces signaling pathways involved in promoting
muscle hypertrophy but not oxidative capacity (Zoll et al., 2006;
Mueller et al., 2011), these mitochondrial measures have not
been examined in COPD patients to date. Distinguishing these
adaptations is important in order to identify and individualize the
most effective rehabilitation strategy for patients with differing
COPD disease severities and functional capacities.
Thus, the aim of this study was to characterize the
locomotor muscle adaptations to EET in patients with severe
COPD, and compare them with adaptations gained through
conventional concentric cycle training. We hypothesize that
patients undergoing EET will demonstrate larger gains in muscle
strength and mass than the CET group when carried out at
the same relative heart rate intensity, and that these gains are
achieved in part through increases in fiber hypertrophy with
no effect on mitochondrial adaptation. To address this aim, we
analyzed functional and structural adaptations within locomotor
muscle of moderate to very severe COPD patients who were
randomized to a 10-week intervention of either EET or CET
training.
METHODS
Participants and Study Design
Ambulatory men aged 50–80 years with confirmed COPD were
recruited from the clinic at the Montreal Chest Institute to
participate in a randomized clinical trial (ClinicalTrials.gov
identifier: NCT01077102 RCT) comparing eccentric to
concentric cycle ergometer training. Patients were diagnosed
according to the Global Initiative for Chronic Obstructive Lung
Disease (GOLD) based on spirometry values corresponding to
moderate (GOLD stage II), severe (GOLD stage III), and very
severe (GOLD stage IV) COPD (Global Initiative for Chronic
Obstructive Lung Disease, 2017). GOLD stages II through
IV are characterized by worsening airflow limitation and in
general, worsening shortness of breath, exercise capacity, and
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muscle function although muscle abnormalities are detectable
in patients with mild to moderate COPD (van den Borst et al.,
2013). Of the total number of participants enrolled in the
RCT (n = 24), 15 patients who were willing to undergo a
muscle needle biopsy before and after the training intervention
are presented here. The ethics review board of the Research
Institute of the McGill University Health Centre approved the
study. Exclusion criteria included (1) severe or unstable cardiac
disease or orthopedic problems that could preclude exercise
participation, (2) supplemental oxygen therapy, (3) current or
recent (within 3 months) exacerbation (defined as worsening
of at least two respiratory symptoms such as dyspnea, sputum
production, sputum color) with duration of three or more days
of systemic steroid or antibiotic use), (4) participation within a
pulmonary rehabilitation program within the preceding year.
Eligible participants provided informed consent and underwent
an initial medical screening, and then were randomly assigned
to the CET or EET group. Prior to any training, all patients
underwent pulmonary function testing, cardiopulmonary
exercise testing, body composition assessment, quantitative
muscle dynamometry, and a muscle needle biopsy at least 1 week
prior to the commencement of training at the Montreal Chest
Institute and the Department of Kinesiology, McGill University.
These procedures were repeated after 10 weeks of training.
Exercise Training
The COPD patients were randomized into an eccentric cycling
(EET) or a concentric cycling (CET) group, both whom
performed the exercise on the same custom-built recumbent
cycle ergometer (Strasbourg, France) in the exercise physiology
lab of the Montreal Chest Institute. For the EET, the pedals were
driven in a backward direction by an electric motor, and the
patient had to maintain a pedaling frequency of 60 rev-min−1 by
exerting a given force against the pedals. Direct visual feedback
related to pedaling frequency and the measured mechanical
power was provided through computer software. For the CET,
patients pedaled in a forward direction at a similar frequency with
feedback.
The training protocol was set at three sessions per week
of 30 min at a target intensity that was derived from
our previous feasibility trial (Rocha Vieira et al., 2011): for
the concentric group, the target cycling power was 60–80%
peak workrate achieved during the baseline incremental
cardiopulmonary exercise test; for the eccentric group, target
intensity was equivalent to four times the power output
corresponding to 60–80% peak workrate of the baseline
incremental cardiopulmonary exercise test (in the concentric
mode). According to our feasibility study, this estimation allowed
for both the EET and CET groups to exercise at a similar relative
HR intensity. In order to prevent muscle damage and soreness
particularly in the EET, all patients underwent a familiarization
period for the first 2 weeks where the intensity was 20–40%
of their target for either 20 min (week 1) or 30 min (week
2). Therefore, the exercise duration was maintained at 30 min
while the intensity was progressively increased to the target level.
Each patient did a 5-min warm-up of unloaded pedaling prior
to starting each session. Heart rate and ratings of perceived
exertion (RPE) using the Borg CR10 Scale for dyspnea and leg
pain were monitored throughout the exercise by the supervising
kinesiologist and research assistant. Training compliance was set
at greater than or equal to attending 80% of the sessions during
the training period.
Outcome Measures and Experimental
Procedures
Peak Aerobic Power
Participants performed a standard symptom-limited peak
incremental exercise test according to established guidelines
(Ross, 2003) on the recumbent cycle ergometer (Strasbourg,
France) in the concentric mode. Power was increased by 5–10
watts/min until exhaustion and peak aerobic power was recorded
for the calculation of cycle training intensity. Heart rate, blood
pressure, and oxyhemoglobin were monitored throughout the
test, and peak oxygen consumption (VO2) and ventilation were
assessed at baseline (MediSoft, Sorinnes, Belgium).
Body Composition
Dual-energy x-ray absorptiometry (DEXA) was performed on
the GE Lunar iDXA scanner (General Electric Healthcare, USA)
to measure the total and regional body composition (fat and lean
mass content) before and after training. Briefly, thigh-specific
lean mass and fat content were determined using regions of
interest (ROI) with GE Lunar EncoreTM software (V.11.20) by
subtracting the lower leg ROI below the tibio-femoral joint from
the total leg mass (distal section of the leg below the iliac crest
and femoral neck).
Serum Creatine Kinase Levels
Blood was obtained using standard arm venipuncture for analysis
of serum creatine kinase, a marker of muscle damage at baseline,
after 2, 5, and 10 weeks of training in both groups.
Muscle Strength
Assessment of the quadriceps muscle isometric peak torque
was done before and after training using a quantitative Biodex
System 4 Dynamometer (Biodex Medical Systems Inc., New
York). Following familiarization with the device and testing
procedures, patients were instructed to produce a maximal effort
contraction of 4 s with the knees flexed at 60◦. After a 10 min rest,
patients were asked to perform five sequential volitional maximal
contractions over a range of motion from 15◦ to 100◦ at 60◦/s to
calculate the total isokinetic work, which was taken as the sum
of the five contractions. Each testing procedure was performed
twice with the right leg and the highest value was used in the
analysis.
Muscle Biopsy Outcomes
A biopsy of the left vastus lateralis at the mid-thigh level was
taken before training and within 4–7 days after the last training
bout using themodified Bergstrom needle technique with suction
(Shanely et al., 2014). An ∼200mg sample of muscle was
obtained and portioned out for the various analyses described
below. With the exception of the mitochondrial respiration assay
which required fresh tissue, muscle was immediately snap frozen
Frontiers in Physiology | www.frontiersin.org 3 March 2017 | Volume 8 | Article 114
MacMillan et al. Eccentric Cycle Training in COPD
in liquid nitrogen or frozen using liquid Isopentane (cooled in
liquid nitrogen) for in-situ labeling, protein western blot analysis,
and mitochondrial enzymatic activity. These samples were stored
at−80◦C until analysis.
Analysis of Mitochondrial Biogenesis Transcript
To detect activation of mitochondrial biogenesis, we quantified
levels of peroxisome proliferator-activated receptor γ coactivator
1α (PGC-1α) mRNA in muscle samples as recently described
(Konokhova et al., 2016). Total RNA was extracted from
samples using the RNeasy Lipid Tissue Mini Kit (Qiagen),
according to manufacturer’ s instructions. RNA concentration
and purity (A 260/A 280 ratios >1.8) were assessed using
a spectrophotometer. RNA (1µg) was reverse transcribed
to cDNA using qScriptTM cDNA Synthesis Kit (Quanta
BioSciences) according to the manufacturer’ s instructions.
The PPARGC1alpha (PGC-1α) primer was designed with
Primer 3 plus [forward TTTCCTTTTGCCATGGAATC,
reverse: GAAAGAACCGCTGAACAAGC (NCBI ref:
XM_005248130.1)]. TATA box binding protein [TBP;
primers: forward TATAATCCCAAGCGGT TTGC-3, reverse
GCTGGAAAACCCAACTTCTG (NCBI ref: NM_001172085.1)]
was used as the reference gene for quantification of mRNA
levels. The cDNA was amplified using Power SYBR R© Green
PCR Master Mix (Life Technologies) as previously described
(Konokhova et al., 2016). All real-time PCR experiments were
performed in triplicates along with melt curve analysis to
assess primer dimer formation or contamination. Then, the
comparative CT method was used to calculate fold changes in
expression in the COPD patients post-training and compared
to baseline levels, where 1CT = CT of PGC-1α gene − CT of
TBP and 11CT = 1CT of patients prior to training − 1CT of
patients following the training intervention.
In-situ Labeling
Muscle sections were cut at either 8 or 10µm thickness using
a cryostat (−20◦C) and mounted on a slide and air-dried. Pre
and post training analyses for each patient were done on similar
thickness sections.
To evaluate evidence of muscle damage, a standard
hematoxylin and eosin stain was performed. To detect fiber
type and analyze fiber cross sectional area, immunofluorescent
labeling for myosin heavy chain slow isoform (MHC type 1)
expression and myosin heavy chain fast isoform (MHC type
2a and 2x) expression was performed as we have previously
described (Konokhova et al., 2016). Muscle sections were
blocked in 10% normal goat serum (Life technologies, 50-062Z)
and incubated with primary antibodies (from Developmental
Studies Hybridoma Bank) for 1 h at RT at specified working
dilutions: BA-F8 (mouse anti-myosin heavy chain (MHC)1
IgG2b, 1:25), Sc-71 (mouse anti-MHC2a IgG1, 1:200), and 6H1
(mouse anti-MHC2x IgM, 1:25). Following three washes in PBS,
sections were probed with the following secondary antibodies:
Alexa Fluor 350 IgG2b (y2b) goat anti-mouse 1:500, Alexa Fluor
594 IgG1 (y1) goat anti-mouse 1:100, Alexa Fluor 488 IgM goat
anti-mouse 1:500, and Alexa Fluor 488 IgG goat anti-rabbit
1:500. Sections were then washed in PCS and mounted using
ProLong gold. Images were captured on a Zeiss Axio Imager M2
fluorescent microscope (Zeiss, Germany). To detect evidence
of mitochondrial biogenesis in situ, we probed for PGC-1α
content (Supplementary Figure 1). Muscle sections were thawed
and fixed in pre-cooled Acetone for 15 min at 4◦C, washed in
TBS (3 × 5 min). Muscle tissue was then permeabilized with
0.1% Triton (Life Technologies; 28314) for 15 min at room
temperature, washed with TBS (3 × 5 min) blocked in 10%
normal goat serum for 15 min at room temperature. Sections
were then probed for PGC1α (AB3242, Millipore, 1:50 dilution)
overnight at 4◦C. Following primary incubation, muscle sections
were washed in TBS (3 × 5 min) and exposed to Alexa Fluor
488 IgG at 1:500 dilution (goat anti rabbit) for 90 min at room
temperature, while protected from light. Sections were washed
again (3 × 5 min TBS) and mounted with Vectashield mountant
(Vector Laboratories, H-1200, Burlingame, CA, USA). Given the
fiber-type variability of PGC-1α content, for this determination
we used the muscle cross-section that was cut immediately
following those used for MHC immunolabelling as we have
previously described (Gouspillou et al., 2014b).
Imaging and Image Analysis
All images were collected using an upright Zeiss microscope
(Carl Zeiss, Germany). Tiled images of the entire muscle biopsy
cross-section were obtained at 10x magnification. The entire
cross-section was imaged and then analyzed in Fiji software,
an open source NIH platform for biological image analysis
(Schindelin et al., 2012) to determine individual fiber cross-
sectional area (CSA,µm2) and to identify pure MHC slow
(type 1) myofibers, MHC fast (type 2a) and MHC fast (type
2x) as well as MHC co-expressing myofibers (more than one
MHC signal). Myofibers that were negative for the other MHC
types were categorized as expressing just the specific pure MHC,
whereas those myofibers having a positive signal in more than
one channel were categorized as co-expressing. On average,
455 ± 226 fibers per patient were counted pre-training and
331 ± 180 fibers per patient were counted post-training. For
the other labeling, 100 or 200x magnification was used. PGC-
1α was quantified using densitometry analysis as previously
described (Gouspillou et al., 2014b). Briefly, individual fibers
were traced using ImageJ software (NIH, USA) and once all
the fibers were traced, the mean gray intensity for each fiber
was determined. Fibers were then matched for MHC signal in a
serial muscle cross-section to obtain fiber type specific data. To
detect if training resulted in muscle damage, H&E labeling was
analyzed for mononuclear infiltration, streaming, and necrosis
by a trained specialist blinded for patient group and biopsy
time in the Neuromuscular Disease Department of the Montreal
Neurological Institute.
Electron Transport Complex Content
Western blot analysis was used to measure protein content
of the mitochondrial oxidative phosphorylation system located
on the inner mitochondrial membrane and the Voltage-
dependent anion channel (VDAC) located on the outer
mitochondrial membrane. Approximately 30–40mg of muscle
was homogenized in 10 vol of an extraction buffer composed of
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50 mM Tris base, 150 mM NaCl, 1% Triton X-100, 0.5% sodium
deoxycolate, 0.1% SDS, and 10µl/ml of a protease inhibitor
cocktail (P8340, Sigma). The homogenate was centrifuged at
15,000 g for 15 min at 4◦C. Protein content in the supernatant
was determined using the Bradford method with BSA as
standard. Aliquots of supernatant were mixed with Laemli
buffer and subsequently boiled at 95◦C for 5 min. Sixteen
micrograms were loaded into 12% gels, electrophoresed by
SDS-PAGE, and then transferred to polyvinylidene fluoride
membranes (Life Sciences). Membranes were incubated for 1
h at room temperature in a blocking buffer composed of 5%
(w/v) non-fat dried milk in Tris-buffered saline containing 0.1%
Tween 20 (TBS-T) and probed overnight at 4◦C with primary
antibodies for mouse monoclonal anti-VADC (Ab14734, 1:1500)
and mouse polyclonal OXPHOS (Ab110413, 1:2000) diluted in
5% non-fat milk. The following day, membranes were washed in
TBS-T and incubated with appropriated Horseradish Peroxidase
(HRP)-conjugated secondary antibodies diluted in 5% BSA
for 1 h at room temperature. Protein signals were detected
using enhanced chemiluminescence substrate (24080; Thermo
Scientific; Waltham, MA, USA), imaged with a G-Box chem
imaging system and analyzed by GeneSys software (Syngene,
Cambridge, UK). Ponceau staining was used to ensure equal
protein loading. VDAC and OXPHOS protein content was
normalized for Ponceau staining that was imaged and analyzed
with the same system.
Mitochondrial Respiration Assay
Permeabilized myofiber respiration was assessed with a
polarographic oxygen sensor (Oxygraph-2k; Oroboros,
Innsbruck, Austria) calibrated as required for O2 concentration,
environmental variables and auto-O2 consumption as routinely
performed in our laboratory (Picard et al., 2010; Gouspillou
et al., 2014a). Briefly, to prepare muscle bundles, fibers were
manually teased apart and permeabilized using buffer A mixed
with 0.05 mg/ml saponin and then placed in buffer B for
respiration. These experiments were performed at 37◦C and
analyzed with a specially developed program using Igor Pro
software (Wavemetrics). Baseline respiration was measured
by placing 3–6mg (wet weight) permeabilized bundles into
the respirometer. Thereafter, the substrate protocol assessing
O2 flux was added sequentially as follows, with each step
interspersed with a period of stabilization between injections:
10 mM glutamate +5 mM malate +2 mM ADP (maximal
ADP-stimulated respiration, State 3, with complex I substrates),
+10 mM succinate (Succ; State 3, with complex I and II
substrates), 10µM antimycin A (AA), and 5 mM ascorbate
+0.5 mM N,N,N′,N′-tetramethyl-p-phenylenediamine (TMPD).
Mitochondrial respiration was analyzed in a subset of patients
(n = 4 per group) due to insufficient tissue extraction from all
biopsies.
Statistics
The sample size was calculated based on a similar study assessing
changes in muscle strength after 8 weeks of EET and CET
in patients with coronary artery disease (Steiner et al., 2004).
Using this and taking into account a 15% patient drop out rate,
we predicted that with 7 patients in each group (n = 14), we
could show a difference in muscle strength between groups.
Statistical analysis was performed using GraphPad Prism (Prism
7, GraphPad Software, Inc.). Results are presented as mean ±
SEM, with significance set at P < 0.05. Data was tested for
normality using the Pearson omnibus normality test. Two-tailed
paired Student’s t-tests were applied to analyze changes from pre-
to post-training within a group, whereas unpaired Student’s t-test
was used to detect intergroup differences. A repeated measures
analysis of variance (ANOVA) was used to determine training
effect on PGC-1α content within the different fiber types.
RESULTS
Baseline Characteristics
Recruitment and randomization from the larger RCT yielded
eight COPD patients in the EET group and seven patients in the
CET group (Table 1). A greater number of patients in the EET
group (87.5%) had more severe airflow obstruction (GOLD III
and IV) compared to CET group (57%). All patients were on
bronchodilators, and there were no differences in use of other
medications between groups (See Supplementary Table 1).
Exercise Training Compliance,
Progression, and Safety
All 15 patients who agreed to undergo a baseline muscle biopsy
completed the 10-week training program and compliance was
similar between groups (EET = 87.0 ± 6%; CET = 85.7 ± 6%
of all sessions, P = 0.66). During the training, one patient in the
EET group experienced an acute exacerbation and one patient
in the CET group experienced low back pain that resulted in
TABLE 1 | Demographic and baseline characteristics of COPD patients by
training group.
Characteristic EET (n = 8) CET (n = 7)
Age (years) 68 ± 2 63 ± 2
Height (cm) 170 ± 3 173 ± 2
Weight (kg) 76 ± 6 79 ± 8
BMI (kg/m2) 26.5 ± 1.9 26.7 ± 2.8
FFMI (kg/m2) 17.5 ± 0.5 18.5 ± 1.0
FEV1 (% Pred. Pβ2A) 36.2 ± 3.7 45.8 ± 5.0
FEV1/FVC (% Pred. Pβ2A) 34.4 ± 3.7 37.2 ± 1.7
GOLD Stage II 1 3
GOLD Stage III 4 3
GOLD Stage IV 3 1
Steps per day 3372 ± 869 4271 ± 655
Data are presented as means ± SE except disease categories where the values are
frequency counts. BMI, Body Mass Index; FFMI, Fat-free mass Index (kg/m2); FEV1,
Forced expiratory volume in 1 s; FEV1/FVC, Forced expiratory volume in 1 s over
forced vital capacity; GOLD, Global Initiative for Chronic Obstructive Lung Disease,
a classification of airflow limitation severity in COPD based on post-bronchodilator
FEV1; Stage II (moderate COPD) characterized by FEV1/FVC<70%; 50%<FEV1 <80%
predicted; Stage III (severe COPD) characterized by FEV1/FVC<70%; 30%<FEV1 <50%
predicted; Stage IV (very severe COPD) characterized by FEV1/FVC<70%; FEV1 <30%
predicted. Pβ2A, Post β2Agonist.
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FIGURE 1 | Data obtained over 10 weeks of training in the EET (closed circles) and CET (open squares) groups. (A) Mean power output expressed in Watts
per week; (B) heart rate expressed as a percentage of baseline maximal heart rate obtained at the end of the incremental cardiopulmonary exercise test; (C) Ratings
of perceived exertion (RPE) using the Borg CR10 scale for leg fatigue during each training session; (D) Ratings of perceived exertion using the Borg CR10 scale for
dyspnea during each training session; (E) serum CK levels at four timepoints. Weekly values for (A–D) represent the average of three exercise sessions per week per
patient. Values are means ± SEM. *Significantly different compared to other group at the same time point, p < 0.05.
their training programs being delayed by 1 week and 9 days,
respectively, until their health status improved. Two patients
in the EET group experienced knee pain during training but
were able to complete training. One patient in the CET group
experienced hip pain but was also able to complete the study.
As shown in Figure 1A, the training load was significantly
higher in the EET group compared to the CET group during
week 1, and this load was progressively increased over the first
4 weeks in both groups until it reached a plateau. By the last
week of training (week 10), the mean training load of the EET
group was three-times higher (145 ± 17 watts) than the CET
group (52 ± 9 watts, P < 0.01). Despite the different training
loads, the relative heart rate intensity (% peak attained at the
pre-training assessment) was similar between groups throughout
the 10-week training program (between 80 and 95% peak HR,
Figure 1B). Significant statistical and clinical differences were
demonstrated for perceptions of leg fatigue (Figure 1C) and
dyspnea (Figure 1D) where patients in the EET group reported a
lower perception of leg fatigue and dyspnea than the CET group
throughout the training program.
For both groups, the level of serum CK was normal at baseline
and fluctuated within the laboratory normal range (5–140 U/L)
during the training period (Figure 1E).
Body Composition
There were no changes in body weight or BMI in either group
after the training period. However, as detected by DEXA, the EET
group experienced a significant decrease in body fat percentage
(pre 32.0± 3.9%; post 30.7± 3.6%, P< 0.05) and a trend toward
increase in total body lean mass content (pre 47.5 ± 2.0 Kg; post
48.3± 1.9 Kg, P = 0.07), whereas no such reductions in body fat
(pre 28.3± 4.7%; post 27.7± 4.4%, P= 0.14) or increases in lean
mass (pre 52.8 ± 2.8%; post 52.2 ± 2.9%, P = 0.13) were seen
in the CET group. Additionally, similar findings were detected
with respect to the thigh: the EET group experienced a decrease in
thigh fat percentage (pre 30.0± 2.5; post 27.9± 2.1 Kg, P< 0.01)
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FIGURE 2 | Changes in quadriceps muscle strength in the EET and CET after training (dark bars). (A) Isometric peak strength; (B) Isometric peak strength
normalized for thigh lean mass; (C) Total isokinetic work. Bar values are means ± SEM **Significant difference compared with pre-training values, p < 0.01.
*Significant difference compared with pre-training values, p < 0.05.
and increase in relative thigh muscle mass (pre 69.3 ± 2.6%;
post 71.3 ± 2.3%, P < 0.01), with no improvements detected
in the CET group (thigh fat percentage pre 24.5 ± 3.3; post
24.5 ± 3.1%, P = 0.92) or thigh muscle mass (pre 75.1 ± 3.8%;
post 75.1± 3.6%, P = 0.93).
Quadriceps Muscle Strength
EET led to significant increases in isometric peak strength as
well as in isometric strength normalized to thigh lean mass
(Figures 2A,B), whereas no such increases were detected in the
CET group. Total isokinetic work (Figure 2C) also increased
significantly post training in the EET group, while there was a
trend for increase in the CET group.
Cardio-Pulmonary Exercise Testing
Peak workrate measured during standard incremental
cardiopulmonary exercise testing did not increase significantly in
the EET group (pre 49.0 ± 6.7; post 54.0 ± 5.8 watts, P = 0.133)
but did in the CET group (pre 62 ± 10; post 73 ± 10 watts,
P < 0.05). However, both groups achieved the minimum
clinically important difference for peak workrate (5 watts) during
incremental exercise testing as defined by Sutherland and Make
(Sutherland and Make, 2005). Technical failure of the metabolic
cart prevented measurement of peak VO2 after training,
and thus, assessment of aerobic training response, in both
groups.
Muscle Ultrastructure and Central Nuclei
Qualitatively, normal muscle ultrastructure was observed in
biopsies of both the EET and CET groups (Figure 3A), and there
was no evidence of increased inflammation or necrosis in the
post-training samples. The proportion of central nuclei relative
to total nuclei (reflecting muscle degeneration/regeneration) did
not increase after training (Figure 3B) in either the EET (pre
5.6 ± 1.1%; post 6.4 ± 1.7%, P = 0.910) or CET (3.2 ± 1.0; post
2.9 ± 1.5%, P = 0.839) groups and did not differ between the
groups in the post training biopsy (P = 0.279). However, there
was one statistical outlier detected in the EET group post training,
with 17% of the nuclei being centralized vs. in the periphery. Data
for this participant was kept in for the analysis as it did not alter
the significance of the conclusions.
FIGURE 3 | (A) Representative muscle biopsy images stained for hematoxylin
and eosin at baseline and after training in the EET and CET group. (B) The
proportion of central nuclei relative to total nuclei in vastus lateralis sections
labeled with DAPI and Laminin pre and post biopsy for the EET and CET
groups.
Muscle Fiber Size and Type
Muscle morphological characteristics are reported in Figure 4.
The average fiber CSA did not change after the intervention in
the EET group (pre 5035 ± 420µm2, post 5141 ± 484µm2,
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FIGURE 4 | Morphometrical analysis of fiber cross-sectional areas (µm2) for (A) the average fiber (not taking fiber type into account); (B) pure Type 1 fibers;
(C) pure Type 2a fibers; (D) fibers that express more than one myosin heavy chain isoform in the Eccentric and Concentric group. The darker shaded bars represent
the post-training value, with the percentage reflecting the mean of the percent change per subject Bar values are means ± SEM. *p < 0.05.
p = 0.824), with variability in both the magnitude and direction
of the fiber-type specific responses (Type 1 CSA from 6109± 551
to 7095 ± 735µm2, p = 0.177, mean ± SEM of difference
per subject = 20 ± 14%; Type 2a CSA from 5628 ± 491
to 5137 ± 471, p = 0.367, mean ± SEM of difference per
subject=−4± 10%; co-expressing fiber CSA from 3735± 1091
to 3955 ± 1421, p = 0.170, mean ± SEM of difference per
subject = 13 ± 15%). Of note, the one patient in the EET
group with the outlier value of centralized nuclei was close to
being a statistical outlier for average fiber CSA, demonstrating a
43% decrease after eccentric training whereas the overall group
change was 5% (25% Standard deviation). In the CET group,
increases were detected in mean CSA (4977± 479 to 5744± 725,
p = 0.053, mean ± SEM of difference per subject = 15 ± 5%),
Type 1 fiber (5607 ± to 7062 ± 847, p = 0.036, mean ± SEM
of difference per subject = 26 ± 9%), Type 2a (5286 ± 700 to
6065 ± 774, p = 0.085, mean ± SEM of difference per subject =
15 ± 9%) with little change in coexpressing fibers (4031 ± 1000
to 4072 ± 1208, p = 0.123, mean ± SEM of difference per
subject = 3 ± 10%). Fiber type proportions (Type 1, Type 2a,
Type 2x) were not significantly altered with either modality of
training (Supplementary Table 2).
Muscle Mitochondrial Adaptations
There was no change in transcript levels of the key mitochondrial
biogenesis regulatory factor PGC-1α after EET (Figure 5A).
In contrast, in the CET group post-training sample, PGC-1α
mRNA was two-fold that of the pre-training value (P < 0.05).
Consistent with this finding, PGC-1α protein levels reflected by
densitometric analysis of immunolabeled muscle fibers did not
change in the EET group within any fiber type, however there was
a main effect of training in the CET group, with higher PGC-1α
content in Type 1, Type 2a, and co-expressing fibers after training
(P < 0.05, Figure 5B).
Analysis of electron transport chain complexes revealed no
changes in the EET group, but significant increases in levels
of Complex 1 and Complex II protein in the CET group
(Figure 5C). We had sufficient tissue to measure mitochondrial
respiration in saponin-permeabilized fibers in 4 patients per
group, revealing no effect of EET on the various states of
respiration (Figure 6). However, significant increases after CET
were detected for maximal ADP stimulated respiration with both
complex I (state 3 respiration GM) and complex I and II (state 3
GMS), and an increase in maximal respiration through Complex
IV (V’ascorbate+ TMPD).
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FIGURE 5 | Changes in markers of mitochondrial biogenesis and content before (open bars) and after (dark bars) training in COPD patients. (A) EET
had no effect on PGC-1α mRNA in contrast to CET. Similarly, (B) EET had no effect on PGC-1α content as detected in situ within specific fiber types, whereas CET led
to an overall increase in PGC-1α content. (C) Analysis of electron transport chain complexes revealed no effect of EET, whereas concentric training increased both
Complex I and Complex II content. Bar values are means ± SEM. **Significant difference compared with pre-training values, p < 0.01.*Significant difference
compared with pre-training values, p < 0.05.
FIGURE 6 | Changes in mitochondrial respiration in permeabilized myofibers of a subset of patients in both the EET (n = 4) and CET (n = 4) groups.
Eccentric ergometer training had no effect, while concentric cycle training increased State 3 (Complex 1 driven), State 3 (Complex I and II driven), and Complex
IV-driven respiration within locomotor muscles of COPD patients. *Significant difference compared with pre-training values, p < 0.05.
DISCUSSION
This study is the first to detail the functional and cellular
responses of locomotor muscle to 10 weeks of eccentric cycle
training in patients with moderate to severe COPD, and contrast
them to conventional endurance training. Patients were able to
overload their muscles, on average, at a workload three times that
of CETwhilemaintaining a similar relative heart rate andwithout
experiencing undue leg fatigue or breathlessness. Consistent
with our hypothesis, EET led to a significant increase in peak
muscle strength whereas CET did not; however, this functional
gain was not associated with a significant increase in average
fiber cross sectional area. Moreover, detailed measurements of
mitochondrial biogenesis, content and function in locomotor
muscles revealed a lack of adaptation to the eccentric cycling
that contrasted with the significant improvements in these
parameters with CET. Taken together, these contrasting muscle
adaptations to EET vs. CET in severe COPD suggest it would
be worthwhile to evaluate a sequential paradigm of eccentric
followed by concentric cycling as a means of augmenting the
training response and skeletal muscle dysfunction in patients
with advanced COPD.
Eccentric Cycling Effects on Locomotor
Muscle Strength and Hypertrophy in COPD
The use of dynamic eccentric exercise is increasingly being
proposed as a therapeutic strategy for individuals with reduced
tolerance for physical activity, due to the ability of eccentric
muscle actions to produce a higher power output for a given
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metabolic, neural, and cardiorespiratory cost compared to
concentric muscle actions (Hortobagyi and DeVita, 2000; Roig
et al., 2008). More specifically, eccentric cycle exercise training
paradigms (whereby the eccentric load is applied continuously
over the pedaling action for time periods consistent with aerobic
exercise) have been shown to result in greater gains in muscle
strength than paradigms consisting predominantly of concentric
muscle actions in healthy young (LaStayo et al., 2000, 2003),
elderly (Mueller et al., 2009), in patients with coronary artery
disease (Steiner et al., 2004) and other clinical conditions (Isner-
Horobeti et al., 2013). In the COPD population, only one
previous study has assessed the impact of eccentric cycle training,
using parameters (10 weeks of cycling at 160 watts) similar to
those in our study but in conjunction with a mixed exercise
training program consisting of aerobic interval training and
strengthening exercises (Rooyackers et al., 2003). The authors
reported improvements in cardiovascular fitness and pulmonary
diffusing capacity in the patients who underwent both EET and
general exercise training but not in the patients who only did
the latter. Importantly, no measurements of muscle function
were included in this prior study. In our current study, we
report significant increases in measures of peak muscle strength
in COPD patients after EET alone. Given the prevalence of
muscle weakness estimated at 30–40% (Seymour et al., 2010)
in this patient population (which tends to affect individuals of
middle to advanced age) and its compromising effects on physical
performance and functional ability, along with the notion
that muscle strength is important in maintaining functional
autonomy in the elderly (Frontera et al., 1988), our findings
support the use of EET as a therapeutic strategy for countering
muscle weakness in COPD.
We expected muscle hypertrophy to accompany the increase
in peak strength after EET, a hypothesis based on previous
findings in healthy muscle showing that when eccentric and
concentric actions are pre-formed at the same metabolic level
during cycle ergometer exercise, the former resulted in a greater
average muscle fiber CSA (LaStayo et al., 2000). In our COPD
patients however, average fiber CSA following EET did not
change from baseline levels and was characterized by both a large
variability in the directionality of fiber-type specific responses
to eccentric training as well as high inter-subject variability in
CSA response. Although not statistically significant, increases in
type 1 fiber (20 ± 14%) and co-expressing fiber (13 ± 15%)
CSA were detected, whereas type 2a CSA decreased (−4± 10%).
An increase in type 1 fiber CSA would theoretically be expected
given the dynamic modality of the exercise whereby the less
fatigable fibers would be recruited throughout the exercise
session, whereas the divergent responses of type 2a and co-
expressing fibers may suggest a transitioning and remodeling of
those fiber types muscle due to the training. The 20% increase
in type 1 fiber CSA may be biologically meaningful, particularly
given the inter-subject variability in response. Of note is one
patient in the EET group who demonstrated a large decrease
(−45%) in CSA, which corresponded to the post-training biopsy
findings indicating the highest level of central nuclei (17%).
This patient was classified with very severe COPD (Stage 4) and
had one of the lowest FFMI and cardiorespiratory fitness levels
at baseline. Whether the variability in response is reflective of
the exercise stimulus or the greater number of patients with
more severe COPD in the EET group is not clear. Despite
randomization, there was an unequal distribution of GOLD Stage
4 patients, with 3 patients in the EET group compared to only
1 in the CET group. Further to this point, although two of the
three patients demonstrated decreases in CSA, the one patient
with Stage 4 disease in the CET group exhibited an increase in
CSA. Indeed, variability in response to exercise rehabilitation
is not uncommon in this patient population (Vogiatzis et al.,
2011).
Interestingly, in patients with coronary artery disease, EET
resulted in a lack of change in average fiber CSA, despite
increases in quadriceps muscle strength (Steiner et al., 2004).
These findings led the authors to assume that gains in neural
coordinative factors accounted for the strength improvement.
These findings are similar to our observations, and although
neural factors were not measured in either study, we can
only assume that a neural improvement accounted for a
portion of the increase in strength after EET in our COPD
patient group. However, we cannot discount the notion that
physiological adaptations, that are known to occur in response
to more classical eccentric resistance training, occurred within
the muscle of our patients. Recent studies have reported
differential muscle growth patterns in response to eccentric and
concentric resistance type training of the quadriceps muscle
in humans, whereby eccentric training promotes longitudinal
muscle growth due to the addition of new sarcomeres in
series, and concentric training promotes transversal hypertrophy
with addition of sarcomeres in parallel (Reeves et al., 2009;
Baroni et al., 2013; Franchi et al., 2015). This explanation is
plausible given the increase in muscle mass observed after
EET without an increase in fiber CSA. Differences in the
regional distribution of hypertrophy have also been reported,
with eccentric training resulting in preferential hypertrophy
of the distal region of the vastus lateralis, and concentric
training impacting predominantly the midbelly (Seger et al.,
1998; Franchi et al., 2014). These findings were based on
the use of ultrasonography to determine changes in muscle
architecture at multiple locations. Finally, classical eccentric
resistance training has been reported to induce extracellular
matrix remodeling, increase tendon stiffness, and improve force
transmission, all of which may contribute to increasing muscle
strength (Heinemeier et al., 2007; Duclay et al., 2009; Mueller
et al., 2011). In our current study however, we are not able to
discern the predominant mechanism(s) underlying the gains in
muscle strength following EET.
In contrast to the EET group, significant increases in
CSA were detected in type 1 fibers of the CET group,
despite the lower muscle workload over the course of 10
weeks. While concentric exercise training does not typically
lead to an increase in fiber CSA in healthy individuals, our
finding is consistent with other studies using conventional
cycle training in COPD patients that report increases in
the average fiber (13%) and type 1 fiber (10–16%) CSA
(Vogiatzis et al., 2005, 2010). This is likely attributable to the
relative state of muscle disuse in COPD patients given their
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sedentary behavior. The increase in fiber CSA in CET did
not translate into detectable improvements in muscle strength,
however peak workrate measured during standard incremental
cardiopulmonary exercise did improve, also consistent with
previous reports in COPD.
EET had a significant impact on body composition with
increases in total body and thigh lean mass detected in the COPD
patients. This is consistent with a previous study reporting a
2.5% increase in thigh muscle mass of healthy elderly individuals
who underwent 12 weeks of EET (Mueller et al., 2009). Of
additional interest was the decrease in body fat and thigh fat
percentage. These findings contrast to those in the CET group
where thigh fat and muscle mass were remarkably similar before
and after training. Reductions in thigh fat content have been
reported in previous studies comparing EET to conventional
resistance training in healthy elderly (Mueller et al., 2009, 2011)
as well in patients with type 2 diabetes after eccentric resistance
combined with aerobic exercise training (Marcus et al., 2008).
Although the basis for these observations is currently unclear,
eccentric resistance exercise has been reported to alter substrate
metabolism in elderly individuals (Krishnan et al., 2003). Further
studies into the interesting effects of EET on body composition
and lipid metabolism are certainly warranted.
Eccentric Cycling Effects on Locomotor
Muscle Mitochondria in COPD
In view of the widely reported decline in muscle oxidative
capacity in COPD (Remels et al., 2007; Gosker et al., 2007a;
Picard et al., 2008; Konokhova et al., 2016) understanding
whether a dynamic exercise paradigm emphasizing eccentric
muscle actions benefits mitochondrial function is important
and relevant for understanding its therapeutic efficacy.
However, consistent with our hypothesis, analysis of
multiple mitochondrial markers reflecting induction of
biogenesis, mitochondrial content, and respiration, revealed no
improvements in the locomotor muscle of COPD patients in
the EET group. Previous studies assessing the mitochondrial
response to EET reported either no change in total mitochondrial
volume density or a down-regulation in expression of genes
involved in mitochondrial biogenesis (PGC-1α) and function
(cytochrome oxidase subunit 4) in healthy young, elderly, and
patients with coronary artery disease (LaStayo et al., 2000; Steiner
et al., 2004; Zoll et al., 2006; Mueller et al., 2011). Interestingly,
in those studies comparing eccentric to concentric cycling
modalities where the metabolic exercise intensity was matched,
the level was such that it did not inducemitochondrial adaptation
in the muscle trained concentrically. In our study, the training
intensity (∼85% of maximal heart rate) resulted in significant
mitochondrial alterations in the group that underwent CET
training, where increases in the key mitochondrial biogenesis
signaling factor (both PGC-1α mRNA and protein) were
detected, along with increases in mitochondrial respiratory chain
complex I and complex II content. Furthermore, these increases
in mitochondrial biogenesis and content were supported by
increases in mitochondrial state 3 and complex IV-driven
respiration in the cohort of patients in whom these analyses were
made, reflecting the improvement in mitochondrial function
after conventional aerobic training. Therefore, our study
adds to previous reports describing divergent mitochondrial
responses to eccentric cycle training and further emphasizes
that even at intensities that impact the mitochondria when
exercised concentrically, eccentric cycle training does not
induce mitochondrial adaptation. Taken together, findings from
these studies highlight the fact that the eccentric modality,
even when done in the dynamic rather than resistance mode,
is associated with a dominant mechanical stimulus at the
expense of metabolic adaptation (Zoll et al., 2006; Mueller et al.,
2011).
Feasibility and Therapeutic Application of
EET in COPD
Given our findings, we believe EET provides a unique strategy in
the context of exercise rehabilitation for patients with moderate
to severe COPD to increase muscle strength. However, an
important consideration in terms of therapeutic application of
EET relates to the safety and feasibility of eccentric cycling.
The notion that eccentric actions induce muscle damage,
injury, and pain likely prevented the application of eccentric
exercise as a therapeutic strategy for clinical populations in
the past, however more recent studies have shown that a
progressive introduction and increase in the intensity, duration
and frequency can minimize or avoid these effects (LaStayo et al.,
2003). Here we confirm the safety of progressively increasing
eccentric cycling intensity over the first 4 weeks, with serum
CK levels remaining within normal limits at weeks 2, 5, and
10 of training. Muscle biopsy analysis revealed no significant
increases on average in the proportion of central nuclei,
further demonstrating that progressive increases in eccentric
workload does not induce muscle damage. Furthermore, patients
reported EET to be relatively effortless as indicated by their
ratings of perceived exertion for both leg fatigue and dyspnea
(reaching no higher than a 3 out of 10 on the Borg rating
scale). In fact, patients in the EET group reported significantly
lower leg fatigue and dyspnea than patients undergoing
conventional cycle training at several time points over the
10-week protocol. This is clinically important and has the
potential to foster compliance to this strategy in a rehabilitation
setting.
EET has been shown to induce numerous functional benefits
in other clinical populations (Isner-Horobeti et al., 2013) that can
be expected to occur in COPD and warrant future study. For
example, eccentric muscle actions have been shown to require
distinct neural input (Enoka, 1996) andmay in fact improve tasks
that involve coordination and movement (Dibble et al., 2006).
EET has been shown to improve neural coordination, functional
tasks (stair descent, timed up and go), and reduce fall-risk in the
healthy elderly (Mueller et al., 2009).
Study Limitations
Despite strengths and unique findings of this study, some
limitations should be taken into account. First, our small sample
size and inclusion of only male patients with moderate to severe
disease may limit the generalizability of our findings to other
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patients with less advanced COPD as well as female patients.
Despite randomization in our study, COPD patients in the EET
group had more patients with very severe disease compared
to the CET group. In terms of peripheral muscle remodeling,
there are conflicting reports that fiber CSA may depend on
COPD disease severity (Eliason et al., 2009; Vogiatzis et al.,
2011), and that the CSA response to high intensity cycle training
may be blunted in patients with severe COPD who have muscle
wasting compared to patients with the same disease severity
who have normal muscle mass (Vogiatzis et al., 2010, 2011).
Clearly, more work is needed to determine what muscle-specific
factors influence the variability of training response in severe
COPD patients. Relating to this variability in muscle response is
the relatively small sample size of patients in our current RCT
who underwent muscle biopsies before and after training, as
well as the biopsy sampling of muscle tissue at only one site in
the thigh. Given the differences in the regional distribution of
hypertrophy to eccentric training described previously, sampling
at multiple sites along the muscle belly to include the distal
and mid portions may have provided more definitive results
as to the efficacy of EET on fiber hypertrophy. In addition,
measurement of fiber CSA in absolute terms from biopsymaterial
has inherent limitations (Zumstein et al., 1983), and it is possible
that the changes in muscle mass and strength after EET may
be difficult to resolve in the biopsy samples. Finally, in terms
of biopsy-related limitations, we only had sufficient tissue to
measure mitochondrial respiration in four patients per group.
We believe it is unlikely that this small sample size explains the
lack of statistical improvement in EET since we were able to
detect significant changes inmitochondrial respiration within the
CET group, and thereby interpret the findings to reflect the lack
of training adaptation, consistent with the other mitochondrial
measures (PGC-1α mRNA and content, electron transport chain
complexes) within the EET group showing no improvement.
We also did not have enough muscle tissue remaining in all
the subjects to examine factors involved in muscle remodeling
and repair (extracellular matrix components, satellite cell and
growth factors; Mueller et al., 2011) or other mechanical
transduction mechanisms that have reportedly been activated
through eccentric resistance exercise (Franchi et al., 2014). This
would have strengthened the notion of whether the EET was
inducing physiological changes within the muscle that could
contribute to increases in muscle strength. A final limitation
relates to the intensity of the EET. First, the intensity was kept
stable after the 4 weeks of training load progression, however
several patients expressed interest in wanting to increase their
weekly training work rate as it felt relatively easy at later points
in the study. This could have influenced the degree of training
response that patients experienced, as progressive overload is
integral to maintaining continual adaptation of skeletal muscle
(Hortobagyi et al., 1996; Lastayo et al., 1999) particularly since
the muscle was sampled after 5 weeks of a plateaued workload.
Second, while the absolute workload (∼150 watts) was three
times higher in the EET group compared to CET, higher
workloads (∼300–340 watts) have been safely applied to healthy
octogenerian men and women and patients with coronary artery
disease (Steiner et al., 2004; Mueller et al., 2009). The greatest
reported magnitude of improvement in muscle strength (36%)
and fiber CSA (52%) was achieved when EET workrate was close
to 500 watts in a group of healthy participants (LaStayo et al.,
2000). Given the safety and tolerability of progressively increasing
the eccentric workload documented in our COPD patients, we
propose future studies to assess the locomotor muscle response
to higher ECC workloads.
Conclusion and Future Study
Although the primary lung pathology in COPD is largely
irreversible, targeting the adaptability of skeletal muscle
through exercise training has therapeutic promise. However,
not only are many patients with advanced disease unable to
participate in exercise rehabilitation, there is great variability in
training responsiveness within the COPD patient population,
emphasizing the need to redesign and personalize the exercise
rehabilitation approach to optimize therapeutic efficacy
(Spruit et al., 2015). Our current study demonstrates the
safety and efficacy of EET in patients with moderate to severe
COPD, and provides evidence for its inclusion into current
pulmonary rehabilitation programs. Our findings reveal
improvements in strength, muscle mass, and composition
of COPD locomotor muscle in response to EET, with no
effect on mitochondrial biogenesis or content. In contrast,
mitochondrial adaptations were detected after CET. Based
on these divergent findings, we propose the use of dynamic
eccentric training to first maximize gains in muscle strength and
mass, allowing patients to subsequently undergo conventional
cycle training at intensities appropriate to more effectively
induce mitochondrial adaptation. High-intensity interval
training has been shown to be more potent in stimulating
mitochondrial biogenesis and respiration compared to constant
load aerobic training (Wisløff et al., 2007; Daussin et al., 2008).
While we have shown a robust mitochondrial adaptation to
CET in our COPD patients, we believe that the proposed
paradigm would allow patients to undergo high-intensity
interval training and thus achieve maximal gains in muscle
oxidative capacity. Tailoring exercise training modalities to best
suit the functional deficits of weakness and fatiguability in the
patient are important, and the proposed paradigm warrants
consideration.
Further understanding of the activation of molecular and
cellular signaling pathways which mediate muscle hypertrophy
and nervous system adaptations in response to EET are
also needed to better understand this training modality. To
confirm the efficacy of EET on increasing muscle mass,
future studies need to include serial ultrasound measurements,
which have shown good reproducibility and sensitivity to
changes in muscle mass in the COPD population compared
to DEXA (Menon et al., 2012). Optimizing the EET cycling
protocol in terms of absolute workload and progression will be
essential in determining the maximal training response. Findings
from this study support the inclusion of EET alone or in
combination with CET into current pulmonary rehabilitation
programs for COPD patients, in order improve skeletal muscle
dysfunction, exercise tolerance, quality of life, and reduce
mortality risk.
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